Fredrik Lindberg

Biography

  Mr. Fredrik Lindberg, M.D., Ph.D. co-founded BoneSupport AB in 1999 and serves as its Senior Advisor. Mr. Lindberg has been the Chief Executive Officer of Enzymatica AB since November 2014. He served as Chief Scientific Officer at BoneSupport AB. He served as the Chief Executive Officer of myFC AB since April 2006. Mr. Lindberg served as the Chief Executive Officer and President of BoneSupport AB until January 2012. From 1989 to 2001, Mr. Lindberg served as a Consultant for the pharmaceutical and biotech industry and for the Swedish Medical Product Agency. Mr. Lindberg served as the Chief Operating Officer of Cellpoint Connect AB (publ) and Chief Executive Officer for two of CellPoints daughter companies, Satsafe Security AB and 112NOW A/S. Mr. Lindberg served as a Medical Director for the Nordic Area at Searle Pharmaceuticals, Division of Monsanto from 1998 to 2000. from 1995 to 1998, he served as the Head of the Department of Clinical Pharmacology at Lund University Hospital, where he had been employed since 1993. He served as an External Director of Enzymatica AB from 2012 to February 2015. Mr. Lindberg was registered physician by the National Swedish Social Welfare Board in 1984 and in 1991 he became Swedish specialist in Clinical Pharmacology. He became an Associate Professor in Clinical Pharmacology at the Medical Faculty, Lund University, Sweden in 1998. He graduated as Ph.D. within Clinical Pharmacology from the School of Medicine at Lund University in 1992. Mr. Lindberg also studied business economics and management at Lund University. Mr. Lindberg received his Master of Science in Electrical Engineering from Lund Institute of Technology.  

Research Interest

 business